Observational studyCurrent oncology (Toronto, Ont.)2022

Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study.

Elodie Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.